Loading...
SciClone Pharmaceuticals, Inc.
SCLN•NASDAQ
$11.15
$0.00(0.00%)
SciClone Pharmaceuticals, Inc. (SCLN) Stock Overview
Explore SciClone Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for SCLNStats details for SCLN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for SCLNAnalyst Recommendations details for SCLN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
Founded
1992